Tianshu Pharmaceutical strictly adheres to regulatory registration requirements to provide services for APIs, including process and quality research, process validation, stability research, registration and approval, and industrialized production.
Tianshu Pharmaceutical is committed to becoming a leading international manufacturer of advanced pharmaceutical intermediates and a provider of comprehensive solutions. Guided by the concept of technological differentiation and the attitude of pharmaceutical development. It researches, develops, and manufactures Regulatory Starting Materials (RSM) and Advanced Drug Intermediates (ADI) to meet the needs of high-end customers for API production and supporting registration services.
Tianshu Pharmaceutical has established specialized impurity synthesis laboratories and preparation laboratories for its impurity research and customization services. It provides reference standards and impurity reference substances for quality research and subsequent commercial production QC testing, along with complete spectra of four major types—Nuclear Magnetic Resonance (NMR), Mass Spectrometry (MS), Infrared Spectroscopy (IR), and Ultraviolet Spectroscopy (UV)—to safeguard customers' R&D, registration, and production processes.